MYM Needs To Learn From FSD Pharma's Mistakes Looks like MYM Nutraceuticals are issuing more common shares again, which will not only hurt the value of shareholder wealth as a result of breaking the "Law of Finance", but will also hurt their chances of IM Cannabis' takeover of the company.
Keep in mind that in order for the acquisition to go ahead, 2/3s of minority shareholders, including those whom are not officers of the company and non institutional investors, must approve it.
The more shares they issue, the lower the chances of IM Cannabis taking over the company.
Obviously, MYM Nutraceuticals didn't learn from FSD Pharma's mistakes in over-issuing shares, which is no wonder why they are at record low levels now.